Industry News
Pharmaceutical Industry News
Ready to rival J&J, Takeda’s growth plan bears fruit with FDA nod for niche lung cancer drug Exkivity
Ready to rival J&J, Takeda's growth plan bears fruit with FDA nod for niche lung cancer drug Exkivity aliu Thu, 09/16/2021 - 05:25
Drug Plan Fails, Signaling Thorny Path for Democrats’ $3.5 Trillion Bill
Senior Democrats said they could still preserve elements of their plan to lower prescription drug prices, but they have little room for defections, and divisions remain on that and other issues.
Democrats’ Stumble on Drug Prices Shows Power of Industry
An attempt in the House to take a bite out of drug companies has been halted for now.
Pharma outreach to LGBTQ community lacking, reveals untapped market beyond HIV and PrEP: survey
Pharma outreach to LGBTQ community lacking, reveals untapped market beyond HIV and PrEP: survey bbulik Wed, 09/15/2021 - 18:11
Study of Covid Booster Shot Benefits Fans Debate Over Extra Doses
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
GlaxoSmithKline’s ‘much-needed’ Shingrix rebound has yet to materialize, analysts say
GlaxoSmithKline's 'much-needed' Shingrix rebound has yet to materialize, analysts say kdunleavy Wed, 09/15/2021 - 16:06
As Pfizer’s booster AdComm nears, FDA staffers say COVID vaccines are already working as intended
As Pfizer's booster AdComm nears, FDA staffers say COVID vaccines are already working as intended esagonowsky Wed, 09/15/2021 - 14:29
ESMO: Facing new Keytruda combos from Merck, BMS touts 5-year kidney cancer data for Opdivo-Yervoy
ESMO: Facing new Keytruda combos from Merck, BMS touts 5-year kidney cancer data for Opdivo-Yervoy aliu Wed, 09/15/2021 - 13:03
BeiGene’s Brukinsa turns up heat against Imbruvica with latest lymphoma nod
BeiGene's Brukinsa turns up heat against Imbruvica with latest lymphoma nod nhigginsdunn Wed, 09/15/2021 - 11:50
ALS Ice Bucket Challenge advocacy group calls for speedy FDA approval of Amylyx now-pending drug
ALS Ice Bucket Challenge advocacy group calls for speedy FDA approval of Amylyx now-pending drug bbulik Wed, 09/15/2021 - 11:28
Floating material found in Pfizer COVID-19 vaccine vials in Japan, but company says it’s not contamination
Floating material found in Pfizer COVID-19 vaccine vials in Japan, but company says it's not contamination kdunleavy Wed, 09/15/2021 - 11:20
ESMO: In unconventional move, Bayer pits genetically driven cancer drug Vitrakvi against Roche’s Rozlytrek in adjusted comparison
ESMO: In unconventional move, Bayer pits genetically driven cancer drug Vitrakvi against Roche's Rozlytrek in adjusted comparison aliu Wed, 09/15/2021 - 10:30
CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington’s intensifying drug-pricing push
CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington's intensifying drug-pricing push esagonowsky Wed, 09/15/2021 - 10:13
Amid COVID’s latest surge, Regeneron and Eli Lilly score new antibody supply deals with the U.S.
Amid COVID's latest surge, Regeneron and Eli Lilly score new antibody supply deals with the U.S. kdunleavy Wed, 09/15/2021 - 09:51
Citing ‘less-than-optimal’ outcomes for Roche’s Evrysdi, Biogen launches high-dose Spinraza trial
Citing 'less-than-optimal' outcomes for Roche's Evrysdi, Biogen launches high-dose Spinraza trial esagonowsky Wed, 09/15/2021 - 09:22
Fred Hutch researchers tout Iclusig’s potential to tame cytokine storm in COVID but can’t get Takeda on board
Fred Hutch researchers tout Iclusig's potential to tame cytokine storm in COVID but can't get Takeda on board kdunleavy Wed, 09/15/2021 - 07:54
Democratic Divisions Flare Over Tax Increases and Drug Pricing
In both the House and the Senate, Democrats are working to resolve their internal differences on a huge social policy measure that will require near-total unity to pass.
Democratic Lawmakers Fracture Over Tax Plans, Drug Prices
Progressive senators pushed back hard on the decision by senior Democrats to focus a $2.1 trillion package of tax increases on income, not wealth.
AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit
AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit esagonowsky Tue, 09/14/2021 - 15:28
Biohaven’s ambitious Nurtec ODT marketing strategy pays dividends with doctors in migraine market: analyst
Biohaven's ambitious Nurtec ODT marketing strategy pays dividends with doctors in migraine market: analyst bbulik Tue, 09/14/2021 - 11:33